Roles of p63 in regulation of miRNA and LincRNA targets in metastatic cancer

p63 在转移性癌症中 miRNA 和 LincRNA 靶标调节中的作用

基本信息

  • 批准号:
    8297085
  • 负责人:
  • 金额:
    $ 50.15万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-05-01 至 2017-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Mortality in cancer is most often due to the development of distant metastases for which almost no effective systemic treatments exist. The study of genes relevant for the regulation of metastasis in vivo is therefore of great importance. The functions of p63, a p53 family member, are beginning to be understood in contexts in which p53 function has been well established, including apoptosis and tumor suppression (Su et al., Nature 2010) as well as in other roles such as metastasis (Su et al., Nature 2010), skin development, and stem cell maintenance (Su et al., Cell Stem Cell 2009). The complexity of p63 function is due in part to the existence of multiple isoforms that previously could not be studied independently. Full length TA isoforms of p63 contain a transactivation domain, structurally and functionally resembling p53, whereas the ?N isoforms of p63, while also possessing transactivation activity, antagonize the activities of p53 and the TA isoforms of p63 and p73, the other p53 family member. Interestingly, mutant p53, present in a wide variety of human cancers, has been shown to interact with p63 isoforms and inactivate their function. By generating and studying mice with isoform-specific null alleles of p63, the TAp63-/- and ?Np63-/- mice, we have shown that these genes have distinct roles in suppression of tumorigenesis and metastasis. TAp63-/- mice are highly susceptible to spontaneous metastatic tumors, and TAp63 potently suppresses tumor metastasis by direct coordinate transcriptional regulation of Dicer and several miRNAs (Su et al., Nature 2010). In addition, we have extended these findings to multiple human tumor types including squamous cell carcinoma, lung adenocarcinoma, and breast adenocarcinoma, indicating this function of TAp63 is widely important. We have also shown that ?Np63 can suppress invasion and transcriptionally regulates DGCR8, another critically important enzyme necessary for miRNA processing. We hypothesize that TAp63 and ?Np63 regulate distinct miRNAs in different cellular compartments to suppress tumorigenesis and metastasis and to engage the DNA damage response. We will address our hypothesis by proposing the following specific aims: Specific Aim 1: To understand the mechanistic regulation of miRNA and LincRNA targets by p63 isoforms in the cell of origin of carcinomas (epidermal cells). Specific Aim 2: To understand the mechanistic regulation of miRNAs and LincRNAs by p63 isoforms in stem cells of skin cancer and metastasis. Specific Aim 3: To understand the roles of miRNAs and LincRNAs regulated by p63 isoforms in the DNA damage response and p53 compensation. PUBLIC HEALTH RELEVANCE: The study of genes relevant for the regulation of metastasis in vivo is of great importance given the high mortality of metastatic cancer, and p63, a p53 family member, plays critical roles to suppress metastasis through coordinate transcriptional regulation of Dicer and microRNAs (miRNAs). The goals of this grant proposal are to identify the miRNA and long non-coding RNA (LincRNA) targets that are regulated by p63 and its isoforms in the suppression of metastasis and the DNA damage response. We will use p63 isoform specific knock out mouse models of metastatic squamous cell carcinoma generated in my laboratory and human patient samples to address this goal.
描述(由申请人提供):癌症死亡通常是由于远处转移的发生,而对此几乎不存在有效的全身治疗。因此,体内转移调控相关基因的研究具有重要意义。 p63(p53 家族成员)的功能在 p53 功能已得到充分确立的背景下开始得到理解,包括细胞凋亡和肿瘤抑制(Su 等人,Nature 2010)以及其他作用,如转移(Su 等人,Nature 2010)、皮肤发育和干细胞维持(Su 等人,Cell Stem Cell 2009)。 p63 功能的复杂性部分归因于以前无法独立研究的多种亚型的存在。 p63 的全长 TA 同工型包含一个反式激活结构域,在结构和功能上与 p53 相似,而 p63 的 ?N 同工型在也具有反式激活活性的同时,拮抗 p53 以及 p63 和 p73(另一个 p53 家族成员)的 TA 同工型的活性。有趣的是,存在于多种人类癌症中的突变 p53 已被证明与 p63 亚型相互作用并使其功能失活。 通过生成和研究具有 p63 异构体特异性无效等位基因的小鼠、TAp63-/- 和 ?Np63-/- 小鼠,我们发现这些基因在抑制肿瘤发生和转移中具有独特的作用。 TAp63-/- 小鼠对自发性转移性肿瘤高度敏感,TAp63 通过 Dicer 和几种 miRNA 的直接协调转录调节有效抑制肿瘤转移(Su 等人,Nature 2010)。此外,我们还将这些发现扩展到多种人类肿瘤类型,包括鳞状细胞癌、肺腺癌和乳腺癌,表明 TAp63 的这种功能非常重要。我们还表明,?Np63 可以抑制侵袭并转录调节 DGCR8,DGCR8 是 miRNA 加工所必需的另一种至关重要的酶。我们假设 TAp63 和 ?Np63 调节不同细胞区室中的不同 miRNA,以抑制肿瘤发生和转移并参与 DNA 损伤反应。我们将通过提出以下具体目标来解决我们的假设: 具体目标 1:了解癌起源细胞(表皮细胞)中 p63 亚型对 miRNA 和 LincRNA 靶标的机制调节。具体目标 2:了解皮肤癌和转移干细胞中 p63 亚型对 miRNA 和 LincRNA 的机制调节。具体目标 3:了解 p63 同工型调控的 miRNA 和 LincRNA 在 DNA 损伤反应和 p53 补偿中的作用。 公共健康相关性:考虑到转移性癌症的高死亡率,体内转移调控相关基因的研究非常重要,而 p63(p53 家族成员)通过 Dicer 和 microRNA (miRNA) 的协调转录调控在抑制转移方面发挥着关键作用。该拨款提案的目标是确定在抑制转移和 DNA 损伤反应中受 p63 及其亚型调节的 miRNA 和长非编码 RNA (LincRNA) 靶标。我们将使用我的实验室生成的 p63 亚型特异性敲除转移性鳞状细胞癌小鼠模型和人类患者样本来实现这一目标。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Elsa R Flores其他文献

Expression and regulation of the ΔN and TAp63 isoforms in salivary gland tumorigenesis clinical and experimental findings.
唾液腺肿瘤发生中 ΔN 和 TAp63 亚型的表达和调节临床和实验结果。
  • DOI:
    10.1016/j.ajpath.2011.03.037
  • 发表时间:
    2011
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Y. Mitani;Jie Li;Randal S. Weber;Scott L Lippman;Elsa R Flores;C. Caulin;Adel K. El
  • 通讯作者:
    Adel K. El

Elsa R Flores的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Elsa R Flores', 18)}}的其他基金

Project 1
项目1
  • 批准号:
    10171099
  • 财政年份:
    2021
  • 资助金额:
    $ 50.15万
  • 项目类别:
Project 1
项目1
  • 批准号:
    10438713
  • 财政年份:
    2021
  • 资助金额:
    $ 50.15万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10438717
  • 财政年份:
    2021
  • 资助金额:
    $ 50.15万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10171103
  • 财政年份:
    2021
  • 资助金额:
    $ 50.15万
  • 项目类别:
Identifying Metabolic Vulnerabilities in Lung Cancer
识别肺癌的代谢脆弱性
  • 批准号:
    10438711
  • 财政年份:
    2021
  • 资助金额:
    $ 50.15万
  • 项目类别:
Identifying Metabolic Vulnerabilities in Lung Cancer
识别肺癌的代谢脆弱性
  • 批准号:
    10171098
  • 财政年份:
    2021
  • 资助金额:
    $ 50.15万
  • 项目类别:
Project 1
项目1
  • 批准号:
    10676731
  • 财政年份:
    2021
  • 资助金额:
    $ 50.15万
  • 项目类别:
Identifying Metabolic Vulnerabilities in Lung Cancer
识别肺癌的代谢脆弱性
  • 批准号:
    10676730
  • 财政年份:
    2021
  • 资助金额:
    $ 50.15万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10676745
  • 财政年份:
    2021
  • 资助金额:
    $ 50.15万
  • 项目类别:
Identification of non-coding RNAs to therapeutically target undruggable pathways in metastatic lung adenocarcinoma and squamous cell carcinoma
鉴定非编码 RNA 以治疗转移性肺腺癌和鳞状细胞癌中不可成药的途径
  • 批准号:
    9903249
  • 财政年份:
    2016
  • 资助金额:
    $ 50.15万
  • 项目类别:

相似海外基金

Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
  • 批准号:
    502556
  • 财政年份:
    2024
  • 资助金额:
    $ 50.15万
  • 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
  • 批准号:
    10659303
  • 财政年份:
    2023
  • 资助金额:
    $ 50.15万
  • 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
  • 批准号:
    10674405
  • 财政年份:
    2023
  • 资助金额:
    $ 50.15万
  • 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
  • 批准号:
    10758772
  • 财政年份:
    2023
  • 资助金额:
    $ 50.15万
  • 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
  • 批准号:
    10676499
  • 财政年份:
    2023
  • 资助金额:
    $ 50.15万
  • 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
  • 批准号:
    2748611
  • 财政年份:
    2022
  • 资助金额:
    $ 50.15万
  • 项目类别:
    Studentship
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
  • 批准号:
    22K05630
  • 财政年份:
    2022
  • 资助金额:
    $ 50.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
  • 批准号:
    10532032
  • 财政年份:
    2022
  • 资助金额:
    $ 50.15万
  • 项目类别:
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
  • 批准号:
    10525070
  • 财政年份:
    2022
  • 资助金额:
    $ 50.15万
  • 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
  • 批准号:
    10689017
  • 财政年份:
    2022
  • 资助金额:
    $ 50.15万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了